Editorials: Cell Cycle Features
Restoring PML tumor suppression to combat cancer
Downloads and Tools
Volume 11, Issue 20 October 15, 2012
Pages 3705 - 3706
http://dx.doi.org/10.4161/cc.22043
Keywords: BMK1, CK2, E6AP, PML, small-molecule inhibitors, tumor suppression
Authors: Kamil Wolyniec, Ai-Leen Chan, Sue Haupt and Ygal Haupt
View affiliations Hide affiliations
- Kamil Wolyniec
-
Tumour Suppression Laboratory; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia; Sir Peter MacCallum Department of Oncology; The University of Melbourne; Parkville, VIC Australia
- Ai-Leen Chan
-
Tumour Suppression Laboratory; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia; Sir Peter MacCallum Department of Oncology; The University of Melbourne; Parkville, VIC Australia
- Sue Haupt
-
Tumour Suppression Laboratory; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia; Sir Peter MacCallum Department of Oncology; The University of Melbourne; Parkville, VIC Australia
- Ygal Haupt
-
Corresponding author: ygal.haupt@petermac.org
Tumour Suppression Laboratory; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia; Sir Peter MacCallum Department of Oncology; The University of Melbourne; Parkville, VIC Australia; Department of Pathology; The University of Melbourne; Parkville, VIC Australia; Department of Biochemistry and Molecular Biology; Monash University; Clayton,VIC Australia
Editorials: Cell Cycle Features to:
K Wolyniec, J Shortt, Stanchina E de, Y Levav-Cohen, O Alsheich-Bartok, I Louria-Hayon, V Corneille, B Kumar, SJ Woods, S Opat, RW Johnstone, CL Scott, D Segal, PP Pandolfi, S Fox, A Strasser, YH Jiang, SW Lowe, S Haupt, Y Haupt. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis. Blood 2012; 120: 822-32
PMID: 22689861 DOI: 10.1182/blood-2011-10-387647
Received: July 9, 2012; Accepted: August 19, 2012; Published Online: September 14, 2012
Preview: